Phase 1 Study of Multikine in the Treatment of Perianal Warts
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Buffy coat interleukins (Primary)
- Indications Anal cancer; Anal dysplasia; Anal intraepithelial neoplasia; Genital warts
- Focus Therapeutic Use
- Sponsors CEL-SCI Corporation
- 17 Aug 2016 Status changed from recruiting to discontinued.
- 09 Feb 2016 According to CEL-SCI media release, this study in expected to complete in the second half of 2016.
- 08 Jan 2016 According to CEL-SCI media release, company has announced on July 2015, expansion of this clinical trial with the addition of the University of California, San Francisco (UCSF) as a second clinical site. Data from this trial is expected in 2016.